Skip to main content

Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL)

NYSEARCA: PILL · IEX Real-Time Price · USD
18.17 -0.38 (-2.05%)
Oct 22, 2021 4:00 PM EDT - Market closed
Expense Ratio1.00%
PE Ration/a
Shares Out1.75M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend DateSep 24, 2019
1-Year Return
Previous Close18.55
Day's Range17.81 - 18.42
52-Week Low15.25
52-Week High31.86
Inception DateNov 15, 2017

About PILL

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Asset ClassEquity
RegionNorth America
IssuerDirexion Investments
Stock ExchangeNYSEARCA
Ticker SymbolPILL
Index TrackedDynamic Pharmaceutical Intellidex Index

Top 10 Holdings

84.35% of assets
Jazz PharmaceuticalsJAZZ0.90%
View More Holdings


Ex-DividendAmountPay Date
Dec 23, 2019$0.00033Dec 31, 2019
Sep 24, 2019$0.01521Oct 1, 2019
Jun 25, 2019$0.02237Jul 2, 2019
Mar 19, 2019$0.05733Mar 26, 2019
Dec 27, 2018$0.09858Jan 4, 2019
Sep 25, 2018$0.04338Oct 2, 2018
Full Dividend History


3 ETFs to Access a Changing Pharmaceutical Industry

A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past ye...

Other symbols:CUREWEBL
2 months ago - ETF Trends

5 Best Leveraged ETFs of Last Week

Wall Street was overall upbeat last week. Though concerns about the spread of the Delta Variant of coronavirus worried investors, low rates boosted the demand for stock investments.

2 months ago - Zacks Investment Research

5 Best Leverage ETF Areas to Watch as Markets Bounces Back

Wall Street started the week on a shaky note due to a spike in U.S. COVID cases, which is a potential threat to economic reopening.

Other symbols:HIBLSILXSOXL
3 months ago - Zacks Investment Research

5 Best Leveraged ETFs of Last Week

We highlight a few leveraged ETF areas that won last week.

4 months ago - Zacks Investment Research

4 Best Leveraged ETFs of Last Week

Wall Street was moderate last week as rising rate concerns weighed on the stocks occasionally.

Other symbols:SOXLUCYB
5 months ago - Zacks Investment Research

3 Pharmaceutical ETFs That Could Be Due For A Rebound

These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.

Other symbols:POTXXPH
6 months ago - Benzinga

PILL Hasn't Been a Bitter ETF to Swallow The Past Month

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is up about 20% the past month, which is making it an easy pill to swallow for traders looking to capitalize on this sub-sector of h...

10 months ago - ETF Trends

Top-Performing Leveraged ETFs of Last Week

Last week was upbeat for Wall Street, with the S&P 500 and Nasdaq recording their best weekly advancement since July, rising about 3.7% and 4.6%, respectively.

Other symbols:DPSTSOXLTNA
1 year ago - Zacks Investment Research

8 Leveraged ETFs That Added At Least 15% Last Week

Wall Street performed decently last week with the S&P 500, the Dow Jones and the Nasdaq Composite adding about 2.5%, 3.8% and 2.5%, respectively.

1 year ago - Zacks Investment Research

4 Best-Performing Leveraged ETF Areas of Last Week

Last week witnessed a tug-of-war between bulls and bears.

1 year ago - Zacks Investment Research

3 Leveraged Healthcare ETFs Soaring This Month

The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic.

Other symbols:CURELABU
1 year ago - Benzinga

7 ETFS That May Not Make It Through 2020

Forecasting the next funds to hit the ETF graveyard can be tricky as the decision to hit the “off” switch lies with the issuer, but a combination of low assets and weak volume usually is widely viewed a...

Other symbols:BDRY
1 year ago - InvestorPlace

Best Leveraged ETF Areas of Last Week

Trade optimism, a third Fed rate cut and some better-than-expected corporate earnings drove the stock market last week.

1 year ago - Zacks Investment Research

5 Leveraged ETFs That Gained More Than 20% in October

We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.

Other symbols:BRZURUSL
1 year ago - Zacks Investment Research

With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF

With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performances ...

2 years ago - Benzinga